as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹133.43
Change
-2.64 (-1.94%)
Open
₹135.1
Prev. Close
₹136.07
Day High
₹137.37
Day Low
₹131.62
Volume Analysis
Traded
16,417
Delivered
9,120
Delivery %
55.55%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year revenue growth (28.4%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹142.41 | ₹139.89 | ₹136.66 | ₹134.14 | ₹130.91 | ₹128.39 | ₹125.16 |
| Fibonacci | ₹139.89 | ₹137.69 | ₹136.34 | ₹134.14 | ₹131.94 | ₹130.59 | ₹128.39 |
| Camarilla | ₹135.01 | ₹134.48 | ₹133.96 | ₹134.14 | ₹132.9 | ₹132.38 | ₹131.85 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-31.39%
1 Week
-6.01%
1 Month
+5.44%
3 Months
-9.12%
6 Months
-11.72%
1 Year
-44.13%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹138.51
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
8.69%
Net margin 9.28% × asset turnover 0.6x × equity multiplier 1.56x
Company Overview
Sector
Healthcare
Market Cap
₹609 Cr
P/E (TTM)
20.5
ROE
12.0%
Book Value
₹98.8
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Fabtech Technologies Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 55/100. The strongest factor is Financial Strength (100/100), while Momentum (15/100) is the weakest area to weigh before deciding. Strong 3-year revenue growth (28.4%).
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- −Earnings include an other income of Rs.34.0 Cr.
- −Company has high debtors of 215 days.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Crisil monitoring report for Q2 FY2027 shows IPO proceeds utilization, with no deviations and 12,574.53 lakh unutilized.
Mr. Kalpesh Chauhan resigns as CFO and KMP effective November 12, 2026.
Fabtech Technologies Limited has informed about Transcript
Recorded earnings conference call for Q2 and half-year FY2026 results available online.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 59 | 104 | 135 | 68 | 121 | 63 | 159 | 75 | 92 |
| Expenses + | 54 | 81 | 116 | 74 | 91 | 74 | 136 | 71 | 82 |
| Operating Profit | 5 | 23 | 18 | -6 | 30 | -12 | 22 | 4 | 10 |
| OPM % | 8.0% | 22.0% | 14.0% | -9.0% | 25.0% | -18.0% | 14.0% | 6.0% | 11.0% |
| Other Income + | 2 | 2 | 3 | 3 | 3 | 7 | 10 | 3 | 14 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 6 | 24 | 20 | -6 | 31 | -7 | 30 | 5 | 22 |
| Tax % | 15.0% | 13.0% | 24.0% | -1.0% | 10.0% | -15.0% | 26.0% | 20.0% | 31.0% |
| Net Profit + | 5 | 20 | 15 | -6 | 28 | -6 | 22 | 4 | 15 |
| EPS in Rs | 2 | 6 | 5 | -2 | 9 | -1 | 5 | 1 | 3 |
| Raw PDF | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | — | 107 | -40 | 18 | 10 | -24 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 133 | 121 | 257 | 194 | 226 | 327 | 411 | 388 |
| Expenses + | 119 | 110 | 225 | 169 | 191 | 288 | 374 | 363 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 37 | 25 |
| OPM % | 11.0% | 9.0% | 12.0% | 13.0% | 15.0% | 12.0% | 9.0% | 6.0% |
| Other Income + | 5 | 2 | 4 | 10 | 6 | 27 | 23 | 34 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 6 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 | 5 |
| Profit before tax | 16 | 11 | 31 | 28 | 36 | 60 | 48 | 50 |
| Tax % | 27.0% | 29.0% | 25.0% | 22.0% | 24.0% | 23.0% | 21.0% | — |
| Net Profit + | 12 | 8 | 23 | 22 | 27 | 46 | 38 | 36 |
| EPS in Rs | 4 | 2 | 7 | 7 | 8 | 14 | 9 | 8 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Sales growth | — | -9 | 112 | -25 | 17 | 44 | 26 | -9 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 | 395 |
| Borrowings + | 1 | 9 | 21 | 35 | 13 | 84 | 70 | 57 |
| Other Liabilities + | 84 | 70 | 83 | 89 | 125 | 170 | 209 | 189 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 699 | 686 |
| Fixed Assets + | 2 | 2 | 5 | 4 | 22 | 94 | 78 | 75 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 29 | 29 |
| Other Assets + | 109 | 116 | 150 | 190 | 226 | 318 | 591 | 582 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 699 | 686 |
| Equity Capital | 0 | 0 | 3 | 3 | 3 | 32 | 44 | 44 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 64 | -9 | -3 | -14 | 60 | -36 | 0 |
| Cash from Investing Activity + | -28 | 4 | -9 | 2 | -30 | -20 | -112 |
| Cash from Financing Activity + | -23 | 6 | 8 | 12 | -12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | -4 | 0 | 18 | -20 | 78 |
| Free Cash Flow | 64 | -9 | -4 | -14 | 59 | -61 | -4 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 417 | -65 | 4 | -15 | 196 | -68 | 34 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Public | 29.04% | 28.83% | 28.57% | 28.49% |
| Promoters | 68.94% | 68.94% | 68.94% | 69.03% |
| FII | 0.03% | 0.08% | 0.02% | 0.02% |
| DII | 1.99% | 2.15% | 2.45% | 2.45% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Fabtech Technologies Ltd (this stock) | 609 | 20.5 | 1.39 | 12.0% |
| Rays Of Belief Limited | 615 | 99.3 | 4.03 | 16.1% |
| Valiant Laboratories Ltd | 570 | 35.2 | 1.72 | -2.55% |
| Wanbury Limited | 676 | 20.3 | 4.3 | 76.5% |
| Haleos Labs Limited | 494 | 38.1 | 2.25 | 8.44% |
| Gaudium Ivf N Women H L | 740 | 32.0 | 4.55 | 24.6% |
| Zim Laboratories Limited | 756 | 365.0 | 2.59 | 1.59% |
Which Mutual Funds Hold Fabtech Technologies Ltd?
Frequently Asked Questions about Fabtech Technologies Ltd
Fabtech Technologies Ltd (FABTECH) closed at ₹133.43 on NSE on 19 November 2026, down 2.64 (1.94%) from the previous close.
Fabtech Technologies Ltd trades on the NSE (National Stock Exchange of India) under the symbol FABTECH.
Fabtech Technologies Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 20.5.
Fabtech Technologies Ltd has a dividend yield of 0.44%.
Fabtech Technologies Ltd's 52-week high is ₹257.0 and its 52-week low is ₹115.0.
Fabtech Technologies Ltd has a market capitalisation of ₹609 crore.
Fabtech Technologies Ltd has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Fabtech Technologies Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.